Top Authors

• Most frequent coverage on PRXL

• 
  TraderMark (3685 followers)

  • Health Care (Especially Contract Research Organizations) Is on the Mend (Fri, Jun 19)
  • Kendle International: The Myth of the Safe Biotech (Tue, Apr 21)
  • Why I'm Buying Kendle International before Earnings (Mon, Nov 3)

  More by TraderMark on PRXL »
• 
  Justin M. Hall (672 followers)

  • 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers (Tue, Aug 25)
  • Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results (Wed, Jul 29)
  • Spectrum Pharmaceuticals: Outlook Remains Very Promising (Mon, Jul 27)

  More by Justin M. Hall on PRXL »
• 
  Bespoke Investment Group (3471 followers)

  • Best and Worst Performing Stocks on Earnings Reports (Sun, Feb 1)
  • Best and Worst Performing Stocks in Reaction to Earnings (Mon, Nov 3)
  • Stocks At or Near 52-Week Highs (Thu, Aug 7)

  More by Bespoke Investment Group on PRXL »

• Most followed authors on PRXL

• 
  TraderMark (3685 followers)

  • Health Care (Especially Contract Research Organizations) Is on the Mend (Fri, Jun 19)
  • Kendle International: The Myth of the Safe Biotech (Tue, Apr 21)
  • Why I'm Buying Kendle International before Earnings (Mon, Nov 3)

  More by TraderMark on PRXL »
• 
  Bespoke Investment Group (3471 followers)

  • Best and Worst Performing Stocks on Earnings Reports (Sun, Feb 1)
  • Best and Worst Performing Stocks in Reaction to Earnings (Mon, Nov 3)
  • Stocks At or Near 52-Week Highs (Thu, Aug 7)

  More by Bespoke Investment Group on PRXL »
• 
  SA Editor Rachael Granby (2020 followers)

  • Wall Street Breakfast: Must-Know News (Tue, Jan 27)

  More by SA Editor Rachael Granby on PRXL »

• Newest authors on PRXL

• 
  Todd Campbell (4 followers)

  • Pundits Are Wrong: Healthcare Reform Will Increase Profits (Thu, Sep 17)

  More by Todd Campbell on PRXL »
• 
  Justin M. Hall (672 followers)

  • 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers (Tue, Aug 25)
  • Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results (Wed, Jul 29)
  • Spectrum Pharmaceuticals: Outlook Remains Very Promising (Mon, Jul 27)

  More by Justin M. Hall on PRXL »
• 
  SA Editor Rachael Granby (2020 followers)

  • Wall Street Breakfast: Must-Know News (Tue, Jan 27)

  More by SA Editor Rachael Granby on PRXL »

• Most commented on PRXL

• 
  Justin M. Hall (672 followers)

  • 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers (Tue, Aug 25)
  • Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results (Wed, Jul 29)
  • Spectrum Pharmaceuticals: Outlook Remains Very Promising (Mon, Jul 27)

  More by Justin M. Hall on PRXL »
• 
  Todd Campbell (4 followers)

  • Pundits Are Wrong: Healthcare Reform Will Increase Profits (Thu, Sep 17)

  More by Todd Campbell on PRXL »
• 
  SA Editor Eli Hoffmann (1014 followers)

  • Wall Street Breakfast: Must-Know News (Tue, Oct 28)

  More by SA Editor Eli Hoffmann on PRXL »